Kolexia
Coiteux Valérie Hématologie
Coiteux Valérie
Hématologie
Hôpital Huriez
Lille, France
188 Activités
307 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie myéloïde chronique BCR-ABL positive Leucémie myéloïde Maladie du greffon contre l'hôte Tumeurs hématologiques Leucémie myéloïde en phase chronique Leucémie aigüe myéloïde Syndromes myélodysplasiques Hémopathies

Collaborateurs

Voir plus
Nicolini Franck
Nicolini Franck
Centre Léon-Bérard, Lyon, France
Etienne Gabriel
Etienne Gabriel
Institut Bergonié, Bordeaux, France
Rousselot Philippe
Rousselot Philippe
Hôpital Saint-Louis, Paris, France
Legros Laurence
Legros Laurence
Hôpital Paul Brousse, Villejuif, France

Industries

Voir plus
Novartis
33 collaboration(s)
Dernière en 2023
Pfizer
5 collaboration(s)
Dernière en 2023
Incyte
4 collaboration(s)
Dernière en 2021
Abbvie
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System: Discontinuation of TyrosIne Kinase Inhibitors (ITK) in Chronic Myeloid Leukemia (LMC) and Impact on the Immune System: a Randomized Comparative Study of Two Therapeutic Strategies
Essai Clinique (CHU Poitiers)   19 mars 2024
BIO-TIMER: Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated With Targeted Therapy: the Model of Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors.
Essai Clinique (CHU Clermont-Ferrand)   29 février 2024
CML: A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia
Essai Clinique (Enliven Therapeutics)   09 janvier 2024
Optimizing the use of bosutinib in patients with chronic-phase chronic myeloid leukemia: Recommendations of a panel of experts from the Fi-LMC (French CML working group).
Bulletin du cancer   11 décembre 2023
Empirical Versus Preemptive Antifungal Therapy: Empirical Versus Pre-emptive (Diagnostic-driven) Antifungal Therapy of Patients Treated for Haematological Malignancies or Receiving an Allogeneic Stem Cell Transplant. A Therapeutic Open Label Phase III Strategy Study of the EORTC Infectious Diseases and Leukemia Groups
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   08 décembre 2023
FLUCLORIC: Randomized Multicentric Phase III Study Comparing the Efficacy of 2 Reduced Intensity Conditioning Regimens (Clofarabine/Busulfan vs Fludarabine/Busulfan) in Adults With AML and Eligible to Allogeneic Stem Cell Transplantation
Essai Clinique (CHU Nantes)   13 novembre 2023
Characteristics, Outcomes, Tfr Rates in Young Adults with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: A French Observational Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
A Phase 2 Study of Ponatinib for Prevention of Relapse after Allotransplantation in FLT3-ITD + AML Patients : The Ponallo Trial
65th ASH Annual Meeting Abstracts   02 novembre 2023
T rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence
65th ASH Annual Meeting Abstracts   02 novembre 2023
MTSA: A Phase II, Multicenter, Open Label Study Evaluating the Efficacy and the Tolerance of Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia (MTSA)
Essai Clinique (CHU Saint-Étienne)   04 mai 2023